(Dynamic Interferential Spinal Cord Stimulation System)
This year, Meagan Medical will start product development on one of the most significant advances in spinal cord stimulation product history. Meagan Medical has over twenty years of experience in the design development and clinical use of interferential current (IFC) stimulation products. We believe that IFC’s medium frequency range of 500-20,000 Hz, in two intersecting currents, which combine to reduce tissue resistance and produce a deeper stimulation field could result in more effective pain relief than standard low frequency spinal cord stimulation and other high frequency SCS systems.
These IFC features have proven advantages:
- The base medium frequency range of 500 to 20,000 Hz lowers tissue resistance allowing the IFC to penetrate deeper into the tissue.
- The interferential current field is created by two intersecting circuits connecting diagonally, creating an X pattern, and a beat frequency is produced deeper in the tissues at a higher amplitude where the two circuits intersect. The beat frequency is a lower frequency equal to the difference of the two circuits, i.e. 4000-3900=100 Hz, and this beat frequency may have a range of 0-250 Hz. Deeper tissue penetration has proven to produce superior pain relief.
Watch the video below. Click in the lower right corner to watch full screen.
M2 will enforce its strong patent position which is supported by confirming research done at the Neuronano Research Center. The patented DISCSS™ product will allow stimulation frequencies similar to the other “high frequency” product, plus it will allow additional frequencies, directional current control, and variable beat frequencies that may improve pain control. MD2’S DISCSS™ patent strength will be bolstered by a patent submission on the DISCSS™ IFC lead, which will further strengthen M2’s position as the leader in IFC-SCS.
Caution: The products discussed on this website are investigational medical devices and are limited by US Federal law to investigational use only.